Group 1 - Company LianTe Technology (SZ 301205) announced on November 11 that its 15th meeting of the second board of directors was held on November 10, 2025, to review the proposal for granting reserved restricted stocks to the incentive objects of the 2024 restricted stock incentive plan [1] - For the year 2024, LianTe Technology's revenue composition is 100.0% from the optical communication industry [1] - As of the report date, LianTe Technology has a market capitalization of 14.1 billion yuan [1] Group 2 - The chairman of Beijing University Pharmaceutical, Xu Xiren, was arrested, and prior to this, police had investigated the group's factory premises [1] - Internal sources indicate that the group's assets were disposed of by Xu, with a significant amount of funds unaccounted for [1]
联特科技：11月10日召开董事会会议